Grey Financial Statements From 2010 to 2025

HYEX Stock  USD 1.38  0.12  8.00%   
Grey Cloak financial statements provide useful quarterly and yearly information to potential Grey Cloak Tech investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Grey Cloak financial statements helps investors assess Grey Cloak's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Grey Cloak's valuation are summarized below:
Grey Cloak Tech does not presently have any fundamental trends for analysis.
Check Grey Cloak financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Grey Cloak's main balance sheet or income statement drivers, such as , as well as many indicators such as . Grey financial statements analysis is a perfect complement when working with Grey Cloak Valuation or Volatility modules.
  
This module can also supplement various Grey Cloak Technical models . Check out the analysis of Grey Cloak Correlation against competitors.

Grey Cloak Tech OTC Stock Profit Margin Analysis

Grey Cloak's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.

Profit Margin

 = 

Net Income

Revenue

X

100

More About Profit Margin | All Equity Analysis

Current Grey Cloak Profit Margin

    
  (0.23) %  
Most of Grey Cloak's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Grey Cloak Tech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Competition

Based on the latest financial disclosure, Grey Cloak Tech has a Profit Margin of -0.2328%. This is 97.92% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The profit margin for all United States stocks is 81.67% lower than that of the firm.

Grey Cloak Tech Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Grey Cloak's current stock value. Our valuation model uses many indicators to compare Grey Cloak value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Grey Cloak competition to find correlations between indicators driving Grey Cloak's intrinsic value. More Info.
Grey Cloak Tech is rated # 3 in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Grey Cloak by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Grey Cloak's OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Grey Cloak Financial Statements

Grey Cloak investors use historical fundamental indicators, such as Grey Cloak's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Grey Cloak. Please read more on our technical analysis and fundamental analysis pages.
Healthy Extracts Inc., through its subsidiaries, researches, develops, and markets natural plant-based products in the United States and internationally. Healthy Extracts Inc. was incorporated in 2014 and is based in Littleton, Colorado. Healthy Extracts is traded on OTC Exchange in the United States.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Grey OTC Stock Analysis

When running Grey Cloak's price analysis, check to measure Grey Cloak's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Grey Cloak is operating at the current time. Most of Grey Cloak's value examination focuses on studying past and present price action to predict the probability of Grey Cloak's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Grey Cloak's price. Additionally, you may evaluate how the addition of Grey Cloak to your portfolios can decrease your overall portfolio volatility.